A1 Refereed original research article in a scientific journal

Preterm birth, poor foetal growth and anxiety disorders in a Finnish nationwide register sample




AuthorsStåhlberg Tiia, Upadhyaya Subina, Khanal Prakash, Sucksdorff Minna, Luntamo Terhi, Suominen Auli, Sourander Andre

PublisherWILEY

Publication year2022

Journal: Acta Paediatrica

Journal name in sourceACTA PAEDIATRICA

Journal acronymACTA PAEDIATR

Number of pages10

ISSN0803-5253

DOIhttps://doi.org/10.1111/apa.16377

Publication's open availability at the time of reportingOpen Access

Publication channel's open availability Partially Open Access publication channel

Web address https://onlinelibrary.wiley.com/doi/epdf/10.1111/apa.16377

Self-archived copy’s web addresshttps://research.utu.fi/converis/portal/detail/Publication/175437810


Abstract

Aim: We examined the associations between preterm birth, poor foetal growth and anxiety disorders among children and adolescents. Additionally, we examined the im-pact of common comorbidities and specific anxiety disorders separately.

Methods: Three  Finnish  registers  provided  data  on  a  nationwide  birth  cohort  of  22,181 cases with anxiety disorders and 74,726 controls. Conditional logistic regres-sion was used to examine the associations.

Results: Extremely very preterm birth and moderate- late preterm birth were associ-ated with increased adjusted odds ratios (aOR) for anxiety disorders (aOR 1.39, 95% CI  1.11–1.75  and  aOR  1.13,  95%  CI  1.03–1.23,  respectively).  Weight  for  gestational  age of less than −2SD (aOR 1.29, 95% CI 1.17–1.42) and −2SD to −1SD (aOR 1.08, 95% CI 1.03–1.14) were associated with increased odds ratios for anxiety disorders. When comorbidities were considered, the associations became statistically insignificant for pure anxiety disorders, but remained significant in the groups with comorbid depres-sive or neurodevelopmental disorders.

Conclusion: Preterm birth and poor foetal growth increased the odds for anxiety dis-orders. However, the associations seem to be explained by the conditions of comorbid depressive  and  neurodevelopmental  disorders.  Comorbidities  should  be  considered  when examining and treating child and adolescent anxiety disorders.


Downloadable publication

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.





Last updated on 2024-26-11 at 14:39